Trial Profile
Add-on Mirabegron in Pediatric Patients With Refractory Overactive Bladder
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 26 Apr 2018
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms Add-on-Mira
- 21 Jul 2016 Status changed from recruiting to completed.
- 23 Jun 2015 New trial record